Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
16 03 2023
Historique:
received: 07 06 2022
accepted: 16 02 2023
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 22 3 2023
Statut: epublish

Résumé

Bacterial antibiotic resistance is a global health concern of increasing importance and intensive study. Although biofilms are a common source of infections in clinical settings, little is known about the development of antibiotic resistance within biofilms. Here, we use experimental evolution to compare selection of resistance mutations in planktonic and biofilm Escherichia coli populations exposed to clinically relevant cycles of lethal treatment with the aminoglycoside amikacin. Consistently, mutations in sbmA, encoding an inner membrane peptide transporter, and fusA, encoding the essential elongation factor G, are rapidly selected in biofilms, but not in planktonic cells. This is due to a combination of enhanced mutation rate, increased adhesion capacity and protective biofilm-associated tolerance. These results show that the biofilm environment favors rapid evolution of resistance and provide new insights into the dynamic evolution of antibiotic resistance in biofilms.

Identifiants

pubmed: 36928386
doi: 10.1038/s42003-023-04601-y
pii: 10.1038/s42003-023-04601-y
pmc: PMC10020551
doi:

Substances chimiques

Anti-Bacterial Agents 0
Aminoglycosides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

275

Informations de copyright

© 2023. The Author(s).

Références

Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Front Biosci. 2001 Oct 01;6:E93-103
pubmed: 11578976
NPJ Biofilms Microbiomes. 2020 Jul 24;6(1):28
pubmed: 32709907
Cell. 2014 Aug 28;158(5):1060-1071
pubmed: 25171407
Mol Biol Evol. 2020 Jun 1;37(6):1563-1576
pubmed: 32027370
Antimicrob Agents Chemother. 2008 Jul;52(7):2463-7
pubmed: 18474578
Microbiol Mol Biol Rev. 2014 Sep;78(3):510-43
pubmed: 25184564
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
APMIS Suppl. 2013 May;(136):1-51
pubmed: 23635385
Int J Med Microbiol. 2007 Nov;297(7-8):503-12
pubmed: 17459765
mBio. 2020 May 26;11(3):
pubmed: 32457248
Cell Host Microbe. 2013 Jun 12;13(6):632-42
pubmed: 23768488
J Infect Chemother. 2014 Dec;20(12):762-7
pubmed: 25179392
Microbiol Spectr. 2017 Jul;5(4):
pubmed: 28752817
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12503-8
pubmed: 18719125
Evol Appl. 2018 Dec 22;12(3):498-507
pubmed: 30828370
Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10412-7
pubmed: 20489182
Chemotherapy. 1997 Mar-Apr;43(2):137-41
pubmed: 9084923
Genome Med. 2018 Aug 23;10(1):65
pubmed: 30103826
Evol Appl. 2019 Jan 21;12(3):365-383
pubmed: 30828361
ISME J. 2019 May;13(5):1239-1251
pubmed: 30647458
Drug Resist Updat. 2013 Dec;16(6):96-107
pubmed: 24594007
J Appl Microbiol. 2007 May;102(5):1187-96
pubmed: 17448154
Front Microbiol. 2021 Feb 26;12:617412
pubmed: 33717007
Mol Microbiol. 2006 Jan;59(1):265-75
pubmed: 16359333
Elife. 2019 Sep 13;8:
pubmed: 31516122
mBio. 2019 Sep 10;10(5):
pubmed: 31506315
NPJ Biofilms Microbiomes. 2019 Nov 6;5(1):34
pubmed: 31728201
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28264855
J Antimicrob Chemother. 2008 May;61(5):1053-6
pubmed: 18256114
Antimicrob Agents Chemother. 2013 Apr;57(4):1968-70
pubmed: 23357771
Gastroenterology. 2020 Feb;158(3):610-624.e13
pubmed: 31605691
Int J Med Microbiol. 2010 Dec;300(8):520-5
pubmed: 20843740
Nucleic Acids Res. 2000 Nov 15;28(22):E97
pubmed: 11071951
BMC Evol Biol. 2013 Jan 28;13:22
pubmed: 23356665
mBio. 2017 Apr 11;8(2):
pubmed: 28400528
Nat Genet. 2011 Nov 13;43(12):1275-80
pubmed: 22081229
NPJ Biofilms Microbiomes. 2021 Jan 11;7(1):3
pubmed: 33431848
mSystems. 2020 Jan 21;5(1):
pubmed: 31964772
Appl Environ Microbiol. 1999 Aug;65(8):3710-3
pubmed: 10427070
BMC Bioinformatics. 2016 Apr 19;17:172
pubmed: 27094401
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
FEMS Microbiol Rev. 2021 Aug 17;45(4):
pubmed: 33320947
PLoS Genet. 2017 Jan 19;13(1):e1006570
pubmed: 28103245
Clin Microbiol Infect. 2015 May;21 Suppl 1:S1-25
pubmed: 25596784
Expert Rev Anti Infect Ther. 2018 Jan;16(1):51-65
pubmed: 29235402
Thorax. 2017 Jan;72(1):40-47
pubmed: 27325751
NPJ Biofilms Microbiomes. 2022 Oct 18;8(1):82
pubmed: 36257971
Nat Commun. 2021 Mar 11;12(1):1606
pubmed: 33707445
Nature. 2001 Jul 26;412(6845):442-5
pubmed: 11473319
FEMS Microbiol Rev. 2022 Mar 3;46(2):
pubmed: 34849798
Environ Microbiol. 2010 Jul;12(7):1957-77
pubmed: 20345943
Microb Genom. 2020 May;6(5):
pubmed: 32375975
Antibiotics (Basel). 2022 Apr 05;11(4):
pubmed: 35453237
Genome Biol. 2014 Nov 07;15(11):490
pubmed: 25418686
Front Microbiol. 2018 Mar 19;9:427
pubmed: 29615988
Infect Dis Now. 2021 May;51(3):236-246
pubmed: 33863677
J Antimicrob Chemother. 2010 Sep;65(9):1955-8
pubmed: 20615927
mSystems. 2020 Jul 28;5(4):
pubmed: 32723793
Antimicrob Agents Chemother. 2015 Sep;59(9):5366-76
pubmed: 26100694
FEMS Microbiol Rev. 2017 May 1;41(3):276-301
pubmed: 28369412
DNA Res. 2014 Dec;21(6):711-26
pubmed: 25281544
Nat Rev Microbiol. 2017 Nov;15(11):689-696
pubmed: 28757648
Gene. 1995 May 26;158(1):9-14
pubmed: 7789817
Infect Immun. 2001 Sep;69(9):5529-37
pubmed: 11500426
mBio. 2016 Aug 16;7(4):
pubmed: 27531906
J Antimicrob Chemother. 2013 Dec;68(12):2921-6
pubmed: 23928022
Nat Microbiol. 2016 Mar 07;1:16020
pubmed: 27572640
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4630-7
pubmed: 27185802
Nat Rev Microbiol. 2022 Oct;20(10):593-607
pubmed: 35149841
Microbiol Rev. 1987 Sep;51(3):341-50
pubmed: 3312985
J Antimicrob Chemother. 2003 Jul;52(1):11-7
pubmed: 12805267
Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14734-14739
pubmed: 31262806
Open Biol. 2019 Jul 26;9(7):190051
pubmed: 31288624
J Bacteriol. 2016 Sep 09;198(19):2564-71
pubmed: 27044625
Bioinformatics. 2016 Nov 1;32(21):3246-3251
pubmed: 27378296
J Proteome Res. 2020 Feb 7;19(2):900-913
pubmed: 31920087
Proc Natl Acad Sci U S A. 2007 May 29;104(22):9451-6
pubmed: 17517606
Science. 2000 May 19;288(5469):1251-4
pubmed: 10818002
Nat Rev Microbiol. 2008 Mar;6(3):199-210
pubmed: 18264116
Front Microbiol. 2017 May 11;8:816
pubmed: 28553265
Nature. 2014 Sep 18;513(7518):418-21
pubmed: 25043002
Sci Transl Med. 2014 Nov 12;6(262):262ra156
pubmed: 25391482
FEMS Microbiol Rev. 2016 May;40(3):373-97
pubmed: 26895713
Expert Rev Anti Infect Ther. 2016 Jul;14(7):613-6
pubmed: 27227426
Clin Infect Dis. 2011 Nov;53(9):e129-32
pubmed: 21890750
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29760140
Mol Gen Genet. 1987 Jul;208(3):439-45
pubmed: 2890081
Mol Microbiol. 2004 Feb;51(3):659-74
pubmed: 14731270
Pathogens. 2013 May 13;2(2):288-356
pubmed: 25437038
Science. 2013 Jun 28;340(6140):1583-7
pubmed: 23812717
Front Microbiol. 2020 Nov 09;11:596227
pubmed: 33240251
Nat Rev Microbiol. 2022 Oct;20(10):621-635
pubmed: 35115704
Antimicrob Agents Chemother. 2018 Nov 26;62(12):
pubmed: 30275089
Antimicrob Agents Chemother. 2013 Nov;57(11):5373-83
pubmed: 23959318
Mol Syst Biol. 2013 Oct 29;9:700
pubmed: 24169403
FEMS Immunol Med Microbiol. 2012 Jul;65(2):183-95
pubmed: 22444301
Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):723-728
pubmed: 31832808
Science. 2017 Feb 24;355(6327):826-830
pubmed: 28183996
Microbiol Spectr. 2015 Jun;3(3):
pubmed: 26185072
Methods Mol Biol. 2014;1151:165-88
pubmed: 24838886

Auteurs

Masaru Usui (M)

Laboratory of Food Microbiology and Food Safety, Department of Health and Environmental Sciences, School of Veterinary Medicine, Rakuno Gakuen University, Hokkaido, Japan. usuima@rakuno.ac.jp.
Institut Pasteur, Université de Paris Cité, UMR CNRS 6047, Genetics of Biofilms Laboratory, 75015, Paris, France. usuima@rakuno.ac.jp.

Yutaka Yoshii (Y)

Institut Pasteur, Université de Paris Cité, UMR CNRS 6047, Genetics of Biofilms Laboratory, 75015, Paris, France.

Stanislas Thiriet-Rupert (S)

Institut Pasteur, Université de Paris Cité, UMR CNRS 6047, Genetics of Biofilms Laboratory, 75015, Paris, France.

Jean-Marc Ghigo (JM)

Institut Pasteur, Université de Paris Cité, UMR CNRS 6047, Genetics of Biofilms Laboratory, 75015, Paris, France.

Christophe Beloin (C)

Institut Pasteur, Université de Paris Cité, UMR CNRS 6047, Genetics of Biofilms Laboratory, 75015, Paris, France. christophe.beloin@pasteur.fr.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH